findmyKOL
Clinical trialNCT05409131CompletedInterventional

Omnipod 5 System Compared to Pump Therapy

SponsorInsulet CorporationEnrollment196Type 1 Diabetes
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Subject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the study provided continuous glucose monitoring system. Participants in France will be offered an optional extension of 12 months of Omnipod 5 System use.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Hopital Sud-Francilien

    Corbeil-Essonnes, France

  • Hospices Civils de Lyon - Centre Du Diabete Diab-Ecare

    Lyon, France

  • Chru de Montpellier, Hopital Lapeyronie - Departement D'Endocrinologie, Diabete, Nutrition

    Montpellier, France

  • Hopital Lariboisiere - Centre Universitaire Du Diabete Et de Ses Complications

    Paris, France

United States
  • Stanford University School of Medicine

    Palo Alto, California, United States

  • Sansum Diabetes Research Institute

    Santa Barbara, California, United States

  • University of Colorado Denver

    Denver, Colorado, United States

  • Atlanta Diabetes

    Atlanta, Georgia, United States

  • Northwestern University

    Evanston, Illinois, United States

  • Joslin Diabetes Center

    Boston, Massachusetts, United States

  • State University of New York, Upstate Medical University

    Syracuse, New York, United States

  • Diabetes & Glandular Disease Clinic, P.A. (dgd Clinic)

    San Antonio, Texas, United States

  • University of Virginia

    Charlottesville, Virginia, United States

  • University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Jul 2022
Primary completion
14 Sept 2023
Completion
10 Jan 2025
Last update posted
16 Sept 2025
Registered enrollment
196
Registry id
NCT05409131
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.